SELDAR PHARMA INC has a total of 11 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are WUXI SHUANGLIANG BIOTECHNOLOGY CO LTD, TECNIMEDE SOC TECNICO MEDICINAL SA and FERRO THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 1 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Hungary | 1 | |
#5 | Israel | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Serbia | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hisamichi Hiroyuki | 10 |
#2 | Maeno Kyoichi | 10 |
#3 | Shimizu Takafumi | 10 |
#4 | Ishihara Tsukasa | 10 |
#5 | Takuwa Tomofumi | 10 |
#6 | Ishikawa Noriko | 10 |
#7 | Shimada Itsuro | 10 |
#8 | Seki Norio | 10 |
Publication | Filing date | Title |
---|---|---|
TW200911251A | Tetrahydroisoquinolin-1-one derivatives or salt thereof |